KFDA set to extend validation waiver for GMP

The Korea Food and Drug Administration is expected to support a plan to recognize the conventional drugs whose GMP (Good Manufacturing Practice) validation was fulfilled based on the in-house regulations of pharmaceutical drug manufacturers.

In a meeting with representatives from drug makers on June 29, the administration expressed its willingness to waiver the new GMP validation procedures...